(Q54586663)

1 June 2018

title

Usefulness of EGFR mutation screening in pleural fluid to predict the clinical outcome of gefitinib treated patients with lung cancer. (English)

1 reference

1 June 2018

0 references

8

Katsuyuki Kiura

1 reference

1 June 2018

author name string

Junichi Soh

1

1 reference

1 June 2018

Shinichi Toyooka

2

1 reference

1 June 2018

Keisuke Aoe

3

1 reference

1 June 2018

Hiroaki Asano

4

1 reference

1 June 2018

Syuji Ichihara

5

1 reference

1 June 2018

Hideki Katayama

6

1 reference

1 June 2018

Akio Hiraki

7

1 reference

1 June 2018

Motoi Aoe

9

1 reference

1 June 2018

Yoshifumi Sano

10

1 reference

1 June 2018

Kazuro Sugi

11

1 reference

1 June 2018

Nobuyoshi Shimizu

12

1 reference

1 June 2018

Hiroshi Date

13

1 reference

1 June 2018

language of work or name

English

0 references

publication date

1 November 2006

1 reference

1 June 2018

International Journal of Cancer

published in

1 reference

1 June 2018

volume

119

1 reference

1 June 2018

issue

10

1 reference

1 June 2018

page(s)

2353-2358

1 reference

1 June 2018

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

cites work

1 reference

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

21 January 2018

1 reference

Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.

21 January 2018

1 reference

Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence

21 January 2018

1 reference

HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients

21 January 2018

1 reference

Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer

21 January 2018

1 reference

Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay.

21 January 2018

1 reference

Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp

21 January 2018

1 reference

A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening

21 January 2018

1 reference

Management of malignant pleural effusions

21 January 2018

1 reference

EGFR mutations in malignant pleural effusion of non-small cell lung cancer: a case report.

21 January 2018

1 reference

DNA-like double helix formed by peptide nucleic acid

21 January 2018

1 reference

Real-time genotyping with oligonucleotide probes containing locked nucleic acids.

21 January 2018

1 reference

Prevalence and clinical impact of Met Y1253D-activating point mutation in radiotherapy-treated squamous cell cancer of the oropharynx

21 January 2018

1 reference

Reporting results of cancer treatment

21 January 2018

1 reference

Unraveling the mystery of prognostic and predictive factors in epidermal growth factor receptor therapy

21 January 2018

1 reference

High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan

21 January 2018

1 reference

EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment

21 January 2018

1 reference

Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib

21 January 2018

1 reference

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers

21 January 2018

1 reference

Amphiregulin is a novel growth factor involved in normal bone development and in the cellular response to parathyroid hormone stimulation

21 January 2018

1 reference

Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in chinese patients with non-small cell lung cancer

21 January 2018

1 reference

Erlotinib in lung cancer - molecular and clinical predictors of outcome

21 January 2018

1 reference

Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.22190

1 reference

1 June 2018

1 reference

1 June 2018